In BRAF or RAS mutant tumor cells, DUSP4, DUSP6, SPRY2, and SPRY4 tend to be highly expressed, allowing tumors to evade regular MAPK signaling pathway feedback (Pratilas et al., 2009). The gene discussed is SPRY4; the disease is neoplasm.